User profiles for J. G. van Hasselt

Coen van Hasselt

Leiden University
Verified email at lacdr.leidenuniv.nl
Cited by 3237

[HTML][HTML] Clinical pharmacokinetics and pharmacodynamics of immune checkpoint inhibitors

…, IF Trocóniz, J Ciccolini, JGC van Hasselt - Clinical …, 2019 - Springer
Immune checkpoint inhibitors (ICIs) have demonstrated significant clinical impact in improving
overall survival of several malignancies associated with poor outcomes; however, only 20…

[HTML][HTML] Integrating clinical metabolomics-based biomarker discovery and clinical pharmacology to enable precision medicine

…, CAJ Knibbe, JGC van Hasselt - European journal of …, 2017 - Elsevier
Novel developments in biomarkers discovery are essential in modern health care, notably
in treatment individualization and precision medicine. Clinical metabolomics, which aims to …

[HTML][HTML] Unraveling antimicrobial resistance using metabolomics

…, M van der Peet, T Hankemeier, JGC van Hasselt - Drug Discovery …, 2022 - Elsevier
The emergence of antimicrobial resistance (AMR) in bacterial pathogens represents a global
health threat. The metabolic state of bacteria is associated with a range of genetic and …

[HTML][HTML] Design principles of collateral sensitivity-based dosing strategies

…, PH van der Graaf, DE Rozen, JGC van Hasselt - Nature …, 2021 - nature.com
Collateral sensitivity (CS)-based antibiotic treatments, where increased resistance to one
antibiotic leads to increased sensitivity to a second antibiotic, may have the potential to limit the …

Systems pharmacology: defining the interactions of drug combinations

JGC Van Hasselt, R Iyengar - Annual review of pharmacology …, 2019 - annualreviews.org
The majority of diseases are associated with alterations in multiple molecular pathways and
complex interactions at the cellular and organ levels. Single-target monotherapies therefore …

[HTML][HTML] Disruption of podocyte cytoskeletal biomechanics by dasatinib leads to nephrotoxicity

RC Calizo, S Bhattacharya, JGC van Hasselt… - Nature …, 2019 - nature.com
Nephrotoxicity is a critical adverse event that leads to discontinuation of kinase inhibitor (KI)
treatment. Here we show, through meta-analyses of FDA Adverse Event Reporting System, …

Pronounced between‐subject and circadian variability in thymidylate synthase and dihydropyrimidine dehydrogenase enzyme activity in human volunteers

…, MJ Deenen, D Pluim, JGC van Hasselt… - British Journal of …, 2016 - Wiley Online Library
Aims The enzymatic activity of dihydropyrimidine dehydrogenase (DPD) and thymidylate
synthase (TS) are important for the tolerability and efficacy of the fluoropyrimidine drugs. In the …

[HTML][HTML] A comparison of mRNA sequencing with random primed and 3′-directed libraries

…, M Soumillon, J Wu, J Hansen, B Hu, JG Van Hasselt… - Scientific reports, 2017 - nature.com
Creating a cDNA library for deep mRNA sequencing (mRNAseq) is generally done by
random priming, creating multiple sequencing fragments along each transcript. A 3′-end-focused …

[HTML][HTML] Renal function, body surface area, and age are associated with risk of early-onset fluoropyrimidine-associated toxicity in patients treated with capecitabine …

D Meulendijks, JGC van Hasselt, ADR Huitema… - European Journal of …, 2016 - Elsevier
Background The objective of this analysis was to determine the factors associated with early
onset treatment-related toxicity in patients treated with capecitabine-based anticancer …

Pharmacokinetic–pharmacodynamic relationships of central nervous system effects of scopolamine in healthy subjects

…, RC Schoemaker, JGC van Hasselt… - British journal of …, 2011 - Wiley Online Library
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • The cholinergic system is important
for different central nervous system functions, including memory, learning and attention. …